Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Novel Technology Transforms Baldness Treatment Using Beard and Body Hair

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Dr-U-Hair-bladness

More Like This

PR Newswire associated0

Novel Device Facilitates Successful No-Shave FUE Transplants for Long Hair with Ease

In 2008, GN Corp initiated research with NCRM, Chennai, Tamil Nadu, India on restoring corneal blindness using buccal tissue epithelial cells. An out of the box idea of Dr. Suryaprakash, Urologist from Hyderabad, India in 2012 to apply buccal (oral) mucosal cells to repair stricture-inflicted male urethra, led to a clinical study, which he presented in NCRM NICHE 2017 in Tokyo, kickstarting a collaboration with Dr. Akio Horiguchi, National Defence Medical College, Japan, as they met in EAU in 2018 (Top right picture). Upon confirming successful cell engraftment in urethral stricture pre-clinical models taking help from the Dept. of Medical Engineering of NDMC between 2018~2023, (Bottom, right picture), now in 2025, clinical application has been initiated in Edogawa Hospital, Tokyo. Main picture: BEES-HAUS team after the first clinical transplant in Edogawa Hospital, Tokyo; Dr.Horiguchi (Centre) with Dr.Shojiro Katoh (President, Edogawa Hospital) standing left to him.

Cell therapy for male urethral stricture: BEES-HAUS clinical application in Edogawa Hospital Japan, reports Dr. Akio Horiguchi in IMORU.

Hair of Istanbul Clinic

Hair of Istanbul Clinic has announced Its new service Revision Hair Transplant

ACCESSWIRE associated0

Smile Hair Clinic: Redefining Hair Transplantation in Turkey

Dr. Bashar Bizrah Introduces Groundbreaking Facelift Technique in MENA Region

PR Newswire associated0

Ulike Attends 2025 AAD Annual Meeting to Highlight IPL Technology Advancements

PR Newswire associated0

TOOsonix receives MDR CE Mark for its new oncology and dermatology device

ACCESSWIRE associated0

Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us